Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs.

One of the main problems with the treatment of metastatic prostate cancer is that, despite an initial positive response, the majority of patients develop resistance and progress. In particular, the resistance to docetaxel, the gold standard therapy for metastatic prostate cancer since 2010, represents one of the main factors responsible for the failure of prostate cancer therapy. According to the present knowledge, different processes contribute to the appearance of docetaxel resistance and non-coding RNA seems to play a relevant role in them. In this review, a comprehensive overview of the miRNA network involved in docetaxel resistance is described, highlighting the pathway/s affected by their activity. Copyright © 2020 Elsevier B.V. All rights reserved.

Citation

Milena Rizzo. Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs. Biochimica et biophysica acta. Reviews on cancer. 2021 Jan;1875(1):188481

Mesh Tags

Substances

PMID: 33217485

search → result